Patents by Inventor Hans Fuernkranz

Hans Fuernkranz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10181010
    Abstract: A genetic surveillance system comprises a communications network and at least one reader-analyzer instrument. The reader-analyzer instrument has a communication interface to communicate over the network. The reader-analyzer instrument is adapted to perform genetic assay analysis of a sample obtained from a member of a population and to generate detection-related data based upon the analysis. The reader-analyzer instrument is adapted to associate qualifying information with the detection-related data and to communicate the associated qualifying information and detection-related data over the network.
    Type: Grant
    Filed: December 10, 2014
    Date of Patent: January 15, 2019
    Assignee: APPLIED BIOSYSTEMS, LLC
    Inventors: Chirag Patel, Hans Fuernkranz, Michael Greenstein
  • Publication number: 20150213192
    Abstract: A genetic surveillance system comprises a communications network and at least one reader-analyzer instrument. The reader-analyzer instrument has a communication interface to communicate over the network. The reader-analyzer instrument is adapted to perform genetic assay analysis of a sample obtained from a member of a population and to generate detection-related data based upon the analysis. The reader-analyzer instrument is adapted to associate qualifying information with the detection-related data and to communicate the associated qualifying information and detection-related data over the network.
    Type: Application
    Filed: December 10, 2014
    Publication date: July 30, 2015
    Inventors: Chirag Patel, Hans Fuernkranz, Michael Greenstein
  • Patent number: 8834698
    Abstract: A method for sorting cells in a biological sample comprising a first type of cells and a second type of cells may comprise introducing the biological sample into a chamber comprising a first surface and a second surface, wherein the first surface is associated with a transparent electrode and the second surface is associated with a photoconductive portion of an electrode. The method may further comprise moving incident light and the photoconductive portion relative to one another so as to illuminate regions of the photoconductive portion and modulate an electric field in the chamber in proximity to the illuminated regions. The method may further comprise separating the first type of cells from the second type of cells in the chamber via dielectrophoretic movement of the first type of cells and the second type of cells caused by the modulated electric field, wherein a dielectrophoretic characteristic of at least one of the first type of cells and the second type of cells has been modified.
    Type: Grant
    Filed: February 8, 2010
    Date of Patent: September 16, 2014
    Assignee: Life Technologies Corporation
    Inventors: Aldrich Lau, Joon Yang, Huan Phan, Steven Sherwood, Hans Fuernkranz
  • Publication number: 20110070587
    Abstract: A genetic surveillance system comprises a communications network and at least one reader-analyzer instrument. The reader-analyzer instrument has a communication interface to communicate over the network. The reader-analyzer instrument is adapted to perform genetic assay analysis of a sample obtained from a member of a population and to generate detection-related data based upon the analysis. The reader-analyzer instrument is adapted to associate qualifying information with the detection-related data and to communicate the associated qualifying information and detection-related data over the network.
    Type: Application
    Filed: August 25, 2010
    Publication date: March 24, 2011
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Hans FUERNKRANZ, Chirag J. Patel, Michael Greenstein
  • Publication number: 20100206731
    Abstract: A method for sorting cells in a biological sample comprising a first type of cells and a second type of cells may comprise introducing the biological sample into a chamber comprising a first surface and a second surface, wherein the first surface is associated with a transparent electrode and the second surface is associated with a photoconductive portion of an electrode. The method may further comprise moving incident light and the photoconductive portion relative to one another so as to illuminate regions of the photoconductive portion and modulate an electric field in the chamber in proximity to the illuminated regions. The method may further comprise separating the first type of cells from the second type of cells in the chamber via dielectrophoretic movement of the first type of cells and the second type of cells caused by the modulated electric field, wherein a dielectrophoretic characteristic of at least one of the first type of cells and the second type of cells has been modified.
    Type: Application
    Filed: February 8, 2010
    Publication date: August 19, 2010
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Aldrich N.K. Lau, Joon Mo Yang, Huan L. Phan, Steven W. Sherwood, Hans A. Fuernkranz
  • Publication number: 20070095669
    Abstract: A method for sorting cells in a biological sample comprising a first type of cells and a second type of cells may comprise introducing the biological sample into a chamber comprising a first surface and a second surface, wherein the first surface is associated with a transparent electrode and the second surface is associated with a photoconductive portion of an electrode. The method may further comprise moving incident light and the photoconductive portion relative to one another so as to illuminate regions of the photoconductive portion and modulate an electric field in the chamber in proximity to the illuminated regions. The method may further comprise separating the first type of cells from the second type of cells in the chamber via dielectrophoretic movement of the first type of cells and the second type of cells caused by the modulated electric field, wherein a dielectrophoretic characteristic of at least one of the first type of cells and the second type of cells has been modified.
    Type: Application
    Filed: October 25, 2006
    Publication date: May 3, 2007
    Applicant: Applera Corporation
    Inventors: Aldrich Lau, Joon Mo Yang, Huan Phan, Steven Sherwood, Hans Fuernkranz
  • Publication number: 20070026426
    Abstract: A genetic surveillance system comprises a communications network and at least one reader-analyzer instrument. The reader-analyzer instrument has a communication interface to communicate over the network. The reader-analyzer instrument is adapted to perform genetic assay analysis of a sample obtained from a member of a population and to generate detection-related data based upon the analysis. The reader-analyzer instrument is adapted to associate qualifying information with the detection-related data and to communicate the associated qualifying information and detection-related data over the network.
    Type: Application
    Filed: April 26, 2006
    Publication date: February 1, 2007
    Applicant: Applera Corporation
    Inventors: Hans Fuernkranz, Chirag Patel
  • Publication number: 20060003339
    Abstract: Methods of detecting targets in a sample are provided. Methods of quantitating targets in a sample are provided. Methods of determining the specificity of a first molecule for a second molecule are provided. Methods of detecting inhibitors or enhancers of an interaction between a first molecule and a second molecule are provided. Methods of measuring the affinity of two different molecules for a different third molecule are provided.
    Type: Application
    Filed: June 30, 2004
    Publication date: January 5, 2006
    Inventors: Hans Fuernkranz, Roy Tan
  • Patent number: 6159705
    Abstract: The present invention makes available a rapid, effective assay for screening and identifying pharmaceutically effective compounds that specifically interact with and modulate the activity of a cellular protein, e.g., a receptor or ion channel. The subject assay enables rapid screening of large numbers of compounds to identify those which act as an agonist or antagonist to the bioactivity of the cellular protein. The subject assay is particularly amenable for identifying surrogate ligands for receptors especially from small molecule or peptide libraries or from peptides produced by an autocrine system.
    Type: Grant
    Filed: September 24, 1997
    Date of Patent: December 12, 2000
    Assignee: Cadus Pharmaceutical Corporation
    Inventors: Joshua Trueheart, Jeremy I. Paul, Hans A. Fuernkranz, Debra Nathan, Scott Holmes